Brief: InflaRx Reports Full Year 2025 Results And Highlights Key Achievements And Expected Milestones
19/03/2026 11:54
March 19 (Reuters) - InflaRx NV IF0G.F: INFLARX REPORTS FULL YEAR 2025 RESULTS AND HIGHLIGHTS KEY ACHIEVEMENTS AND EXPECTED MILESTONES Source text: ID:nGNX9N0hY Further company coverage: IF0G.F ((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Inflarx NV
See all newsBrief: Inflarx NV Files For Offerng Of Ordinary Shares, Size Not Disclosed - SEC Filing
Brief: InflaRx Reports Full Year 2025 Results And Highlights Key Achievements And Expected Milestones
Brief: Inflarx Announces Late-Breaker Oral Presentation On Vilobelimab Phase 3 Results In Pyoderma Gangrenosum At 2026 American Academy Of Dermatology Annual Meeting
Brief: Inflarx NV Executing 30% Workforce Reduction
Brief: Inflarx Provides Update On Phase 3 Data Analyses For Vilobelimab In Pyoderma Gangrenosum